Rheumnow Podcast cover image

ACR24 - Day4a

Rheumnow Podcast

00:00

Assessing the Safety of JAK Inhibitors: Insights from ACR 2024

This chapter discusses the safety of JAK inhibitors following the ACR 2024 meeting, highlighting the lack of new safety concerns and ongoing evaluations of treatment-related risks. Experts express hope for expanded applications of JAK inhibitors based on supportive safety evidence.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app